Matthew Perry
Director/Board Member chez XOMA CORPORATION
Fortune : 283 766 $ au 31/03/2024
Profil
Matthew D.
Perry is the founder of Nordic Biotech Advisors ApS.
He currently holds positions as an Independent Director at XOMA Corp.
and as President at Biotechnology Value Fund LP.
Previously, he served as an Independent Non-Executive Director at CTI BioPharma Corp., President & Director at BVF, Inc., Director at Ziarco Pharma Ltd., and President & Portfolio Manager at BVF Partners LP.
He also worked as an Account Executive at Feinstein Kean Partners, Inc. and Feinstein Kean Healthcare.
Perry received his undergraduate degree from The College of William & Mary in 1994.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XOMA CORPORATION
0,10% | 18/03/2024 | 11 799 ( 0,10% ) | 283 766 $ | 31/03/2024 |
Postes actifs de Matthew Perry
| Sociétés | Poste | Début |
|---|---|---|
| XOMA CORPORATION | Director/Board Member | 16/02/2017 |
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Founder | - |
Biotechnology Value Fund LP
 Biotechnology Value Fund LP Investment ManagersFinance Part of BVF, Inc., Biotechnology Value Fund LP is an Alternative Investment Manager. The private company is based in San Francisco, CA. | President | - |
Anciens postes connus de Matthew Perry
| Sociétés | Poste | Fin |
|---|---|---|
| CTI BIOPHARMA CORP. | Director/Board Member | 23/06/2023 |
Feinstein Kean Partners, Inc.
 Feinstein Kean Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Ogilvy Government Relations, Feinstein Kean Partners, Inc. is a public relations firm. The private company is based in Cambridge, MA. Feinstein Kean Partners was acquired by Ogilvy Public Relations Worldwide, Inc. on November 08, 1999. | Corporate Officer/Principal | 01/12/1996 |
Feinstein Kean Healthcare
 Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Corporate Officer/Principal | 01/01/1996 |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Director/Board Member | - |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | President | - |
Formation de Matthew Perry
| The College of William & Mary | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| XOMA CORPORATION | Health Technology |
| Entreprise privées | 8 |
|---|---|
Biotechnology Value Fund LP
Biotechnology Value Fund LP Investment ManagersFinance Part of BVF, Inc., Biotechnology Value Fund LP is an Alternative Investment Manager. The private company is based in San Francisco, CA. | Finance |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
BVF, Inc.
 BVF, Inc. Investment Banks/BrokersFinance BVF, Inc. manages engages in investment business and manages biotech focused hedge funds. The firm manages Biotechnology Value Fund LP and Biotechnology Value Fund II LP. The company was founded by Mark Nathan Lampert on September 14, 1993 and is headquartered in San Francisco, CA. | Finance |
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Finance |
Feinstein Kean Partners, Inc.
Feinstein Kean Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Ogilvy Government Relations, Feinstein Kean Partners, Inc. is a public relations firm. The private company is based in Cambridge, MA. Feinstein Kean Partners was acquired by Ogilvy Public Relations Worldwide, Inc. on November 08, 1999. | Commercial Services |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Finance |
Feinstein Kean Healthcare
Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Commercial Services |
Ziarco Pharma Ltd.
Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Health Technology |
